Related references
Note: Only part of the references are listed.Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Elaine Ku et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)
Nigel D. Toussaint et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial
Barbara Ruggiero et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD
Geoffrey A. Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
Markus Ketteler et al.
ANNALS OF INTERNAL MEDICINE (2018)
Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD A Secondary Analysis from a Controlled Diet Balance Study
Elizabeth R. Stremke et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
Amarnath Marthi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial
Eleonora Riccio et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial
Csaba P. Kovesdy et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA
Nigar Sekercioglu et al.
PLOS ONE (2017)
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
Alexander Grabner et al.
SCIENTIFIC REPORTS (2017)
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD
Sophie Liabeuf et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Shunsuke Yamada et al.
BONE (2017)
Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials
Leena Patel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials
Suetonia C. Palmer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis
Nigar Sekercioglu et al.
PLOS ONE (2016)
Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis
Suetonia C. Palmer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
Geoffrey A. Block et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Effects of Sevelamer Carbonate on Advanced Glycation End Products and Antioxidant/Pro-Oxidant Status in Patients with Diabetic Kidney Disease
Elena M. Yubero-Serrano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis
Chun-Juan Zhai et al.
RENAL FAILURE (2015)
Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
Keitaro Yokoyama et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis
Jeffrey J. Hsu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial
Pablo Urena-Torres et al.
BMC NEPHROLOGY (2014)
Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease
Michael E. Seifert et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
Tamara Isakova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study
Marcelo M. Lemos et al.
CLINICAL NEPHROLOGY (2013)
The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients
Sagrario Soriano et al.
CLINICAL NEPHROLOGY (2013)
Cardiovascular Effects of Sevelamer in Stage 3 CKD
Colin D. Chue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
Sophie A. Jamal et al.
LANCET (2013)
COSMOS: the dialysis scenario of CKD-MBD in Europe
Jose Luis Fernandez-Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review
Chenglong Zhang et al.
BMC NEPHROLOGY (2013)
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
Abdullah Ozkok et al.
BMC NEPHROLOGY (2013)
Phosphate Binder Use and Mortality Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of Possible Confounding by Nutritional Status
Antonio Alberto Lopes et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
Biagio Di Iorio et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Effects of Phosphate Binders in Moderate CKD
Geoffrey A. Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk
Nigel D. Toussaint et al.
NEPHROLOGY (2012)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
Conall M. O'Seaghdha et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease
Wajeh Qunibi et al.
BMC NEPHROLOGY (2011)
Outcomes Associated With Phosphorus Binders in Men With Non-Dialysis-Dependent CKD
Csaba P. Kovesdy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Serum Phosphate and Mortality in Patients with Chronic Kidney Disease
Helen Eddington et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
Mohamed M. Nasrallah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
Robert N. Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Phosphorus Binders and Survival on Hemodialysis
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
D. Russo et al.
KIDNEY INTERNATIONAL (2007)
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community
Ravi Dhingra et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
M Tonelli et al.
CIRCULATION (2005)
A note on variance estimation in random effects meta-regression
K Sidik et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2005)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
How should meta-regression analyses be undertaken and interpreted?
SG Thompson et al.
STATISTICS IN MEDICINE (2002)
Share Paper
